SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Quantum Art: “Employees value a clear mission and stability more than flashy perks”

Anduril explores Israeli expansion as defense-tech boom accelerates

Amdocs’ layoffs fail to halt share slide

U.S.-Iran deal to alter Israel’s strategic and economic environment

Buzz

Most popular

Daily

Weekly

1

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

2

Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat

3

"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"

4

Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR

5

Two years after a $2.7 billion return to Google, AI pioneer Noam Shazeer is leaving for OpenAI

Nestlé

3 stories about Nestlé

גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki

Investors are hopeful, but the company must now face an uphill battle in a crowded market.

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

A Beloved Israeli Snack Prepares to Take Bigger Bite Out of American Market

07.02.19|Navit Zomer

Generations of Israeli kids grew up eating peanut butter flavored snack Bamba. Now, manufacturer Osem is negotiating a distribution agreement that could make the snack as wildly popular with American kids